the role and impact of biotechnology in the next industrial revolution 2c - j. dupont.pdf ·...
TRANSCRIPT
The role and impact of
biotechnology in the next
Industrial Revolution
OECD 5 March 2014
Joanna Dupont-Inglis
Director, Industrial Biotechnology
EuropaBio
What do we do?
EuropaBio Members
- SMEs- Large companies- National associations- Associate members
Stakeholders
- Other industries
- NGOs
- VCs
- Science institutes
European Institutions & Member States
- European Parliament- European Commission- Council of ministers- Member States- Agencies
EuropaBio
• Created in 1996 to provide a voice for the biotech industry in Europe
• Representing the entire biotech sector: Healthcare, Agriculture and Industrial
• 56 corporate members operating worldwide, 14 associate members & BioRegions as well as 19 national biotechnology associations (2000 SMEs)
Kekule Cyclus XV
Why Healthcare biotechnology?
• 350 million patients around the world benefiting from biotech medicine
• Healthcare biotech estimated to account for more than 20% of all marketed medicines
• By 2015 50% of all medicines will come from biotech• Healthcare biotech comprises of more than 1700 companies and a market worth more than €17 billion in Europe alone
Future trends:
• Personalised medicines – increasingly localised treatments• Advanced therapies – cell, gene and tissue engineering
Why Agricultural biotechnology?
• More than 18 million farmers grew GM crops on more than 175 million hectares of land globally in 2013
• Agricultural biotech can increase yields by 6%-30% on the same amount of land helping preserve land for wildlife and biodiversity
• Helps reduce fuel use and CO2 emissions through reduced tillage and helps protect soil from compaction and erosion
Future trends:
• New traits with societal benefits eg. Optimised oil and starch content, improved nutrient profiles and drought tolerance
Why biotechnology?
Why industrial biotech
Why industrial biotech and biobased
economy?
Oil-Age will end long before we run out of oil…
A brief
moment
in history
Living of the land Living of the land (again)
…and while running out,
it will become much more expensive
Why to go biobased?
9
Energy security
• Reduce dependence on imports with locally sourced and produced innovative goods and products***
• Create over 1 million jobs between 2010 and 2030 mainly in rural areas**
• A global biobased market estimated at €200 billion by 2020*Growth
Jobs
Energyand Products
* McKinsey / World Economic Forum
** Bloomberg New Energy Finance
*** European Commission
Why to go biobased?
10
Energy security
• Enhanced and new product functionality
• Up to 90% CO2 saving
• Considerable energy consumption reductionEnergy saving
CO2 reduction
Product functionality
Why Industrial biotechnology?
Pulp and paper
production & bleaching
• Reduction of the amount of chlorine chemicals
by 10% to 15%
• Up to 40% reduction of energy during bleaching
process
Why Industrial biotechnology?
Why Industrial biotechnology?
Where are we in Europe?
• Excellent knowledge base
• World leader on industrial biotechnology
• High appreciation towards sustainability
But…• Lagging behind on implementation & market development
• Strong regulatory environment
• Lack of long term vision and policy coherence
Pre-requisites for competitive biobased industries
1. Coherent, comprehensive and integrated policy
2. Access to renewable raw material at competitive
prices
3. Targeted research and innovation (and particularly
demonstration projects)
4. Market pull for biobased products
5. Communication and awareness raising
Coherent, comprehensive and integrated policies
Biobased
Industries
Agri
Envi
Energy
Regio
Industry
R&I
• Horizon 2020
• Bioeconomy
Strategy
• LMI
• Structural
funds
• EIPs
• Waste
regulations
• Packaging
regulations
• ERA-NETs
• ETPs
• Industrial
policy
• Resources
Efficiency policy
• Common
Agricultural
Policy
• EU 2020
• Renewable
Energy Directive
• Fuel Quality
Directive
• ILUC
• Key Enabling
Technologies
• PPPs
And the same applies at national,
regional and local level
Access to renewable raw material at
competitive prices
No feedstock
=
No biobased industries
Access to renewable raw material at competitive prices
• New market creation
• Rural economies revitalisation
• Diversification of farmer’s incomes
Wheat & Grain Maize Yield (T/ha) - Source: Eurostat
Targeted research and innovation
Problem: Time lag from
research results to marketable
products
Root Cause: Poor access to public money for high-cost demo and flagship plants
Outcome: EU research
commercialised elsewhere
Targeted research and innovation
1124
92
32
28
2
5848
6
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Demonstration
Applied research
Basic research/FP7
Source: OECD “Research & Development Statistics”
Targeted research and innovation
€ 3,8 billion over 7 years (2014-2020)
•Fostering a sustainable biomass supply and building new value chainsFeedstock
•Optimising efficient processing through R&D and upscaling in pilot, demo/flagship biorefineriesBiorefineries
•Developing markets for biobased products and optimising policy frameworks
Markets, products
and policies
An integrated value chain approach
Market pull for biobased products
=
or
≠
Market pull for biobased products
USA
• Biobased Products Defined
• Federal ProcurementPreference
• Voluntary Certification and Labeling
• USDA Certified Biobased Label
Europe
• CEN/TC 411
• No public procurement
preference
Market pull for biobased products
USA• Qualifying Renewable Chemical Production Tax Credit Act of 2013
• Biorefinery Assistance Program
Europe
• Lead Market
Initiative
• National initiatives
(Italy)
Communication and awareness raising
• Consumers
• Industry
• Decision makers
• NGOs
• …
http://biobasedindustries.europabio.org/
The potential is in the land
